Spoštovani kupci!
Zaradi prenove spletne strani in prehoda na OJS spletna prodaja trenutno ne dela. Prosim, če sporočite, kaj bi radi kupili, na prodaja@medrazgl.si. Dopišite vaše ime in priimek, naslov ter način plačila (s predračunom, ob povzetju ali z gotovino, če prezvamete gradivo v živo v prostorih uredištva v času uradnih ur).
Hvala za razumevanje!
MENU
Anatomy
Anesthesiology
Biochemistry
Biomedical Informatics
Biophysics
Cell Biology
Clinical Cases
Dentistry
Dermatovenerology
Emergency Medicine
Family Medicine
Forensic Medicine
Gynecology and Obstetrics
Histology and Embryology
History of Medicine
Human Genetics
Hygiene
Infectious Diseases
Internal Medicine
Medical Deontology and Philosophy
Medical Psychology
Microbiology and Immunology
Neurology
Occupational Medicine
Oncology
Ophthalmology
Orthopaedics
Otorhinolaryngology
Pathology
Pathophysiology
Pediatrics
Pharmacology and Experimental Toxicology
Physical and Rehabilitation Medicine
Physiology
Psychiatry
Radiology
Social Medicine
Surgery
Toxicology
Research papers
Clinical research paper
Preclinical research paper
Sponsored articles
Archive » 1996 » 4 » | Archive » Medical field » Fields » Psychiatry »

Forty-five years of neuroleptics

 
Abstract:

This post is also available in: English Slovenščina (Slovenian)

Neuroleptics were discovered by chance in 1950. Since then, a substantial body of clinical experiences has been collected. The understanding of mechanisms of their action stimulated the development of new theories about the causes of mental disorders. Neuroleptics are symptomatic drugs, because they do not affect the principal causes of mental disorders. The authors give a brief historical review of the development of neuroleptics, and discuss in detail their pharmacokinetics, mechanisms of action and side effects. Clinical efficacy of neuroleptics is illustrated by a number of examples, and some guidelines for a rational use of these drugs are given. Polypharmacy should be avoided and the dosage individualised. The patient’s response to treatment should be evaluated no sooner than four to six weeks after the initiation of therapy. The authors review the latest achievements in the search for new neuroleptics, which are excepted to treat more effectively negative manifestations of schizophrenia and to cause fewer side effects.

Authors:
Šteblaj Anton, Tavčar Rok, Dernovšek Mojca Zvezdana

Keywords:
antipsychotic agents, psychotic disorders – drug therapy

Cite as:
Med Razgl. 1996; 35: 567–79.

Download PDF >>
© 2024 Društvo Medicinski razgledi | Na vrh strani / To top ↑